{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:37:19Z","timestamp":1793619439621,"version":"4.5.0"},"reference-count":92,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In the context of the need to increase treatment options for substance use disorders, recent research has evaluated the therapeutic potential of psychedelics. However, there is an incomplete understanding of psychedelics\u2019 effects on craving, a core symptom of addictive disorders and a predictor of substance use and relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To determine if the use of psychedelics is associated with changes in craving in humans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review of the literature, using PubMed, PsycInfo, and Scopus databases up to May 2023. We included all studies assessing any substance craving levels after psychedelic use (protocol registration number CRD42021242856).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirty-eight published articles were included, corresponding to 31 studies and 2639 participants, pertaining either to alcohol, opioid, cocaine, or tobacco use disorders. Twelve of the 31 included studies reported a significant decrease in craving scores following psychedelic use. All but two studies had methodological issues, leading to moderate to high risk of bias scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Some psychedelics may show promising anti-craving effects, yet the diversity and high risk of bias of extant studies indicate that these results are to be considered with caution. Further well-controlled and larger-scale trials should be encouraged.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811241308613","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T06:37:22Z","timestamp":1738391842000},"page":"149-165","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of psychedelics on craving in addiction: A systematic review"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0869-001X","authenticated-orcid":false,"given":"Sophie-Ath\u00e9na","family":"Chapron","sequence":"first","affiliation":[{"name":"University of Bordeaux, Bordeaux, France"},{"name":"SANPSY, CNRS UMR 6033, Bordeaux, France"},{"name":"Service d\u2019Addictologie, Center Hospitalier de la C\u00f4te Basque, Bayonne, France"},{"name":"Addiction Clinic, Pole Inter\u00e9tablissement d\u2019Addictologie, CHU de Bordeaux et CH Charles Perrens, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5924-7766","authenticated-orcid":false,"given":"Guilhem","family":"Bonazzi","sequence":"additional","affiliation":[{"name":"University of Lyon 1, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0328-338X","authenticated-orcid":false,"given":"Laura","family":"Di Lodovico","sequence":"additional","affiliation":[{"name":"Clinique des Maladies Mentales et de l\u2019Enc\u00e9phale, H\u00f4pital Sainte Anne, GHU Paris Psychiatrie et Neurosciences, Paris, France"},{"name":"INSERM U1215, NeuroCentre Magendie, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"de Ternay","sequence":"additional","affiliation":[{"name":"University of Lyon 1, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Landmann","sequence":"additional","affiliation":[{"name":"University of Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0952-0091","authenticated-orcid":false,"given":"Mikail","family":"Nourredine","sequence":"additional","affiliation":[{"name":"University of Lyon 1, Lyon, France"},{"name":"Service de Biostatistiques de Lyon, Hospices Civils de Lyon, Lyon, France"},{"name":"Laboratoire de Biom\u00e9trie et Biologie \u00c9volutive, CNRS UMR 5558, Lyon, France"},{"name":"Service Hospitalo-Universitaire de Pharmaco-Toxicologie de Lyon, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salvo","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1212-6060","authenticated-orcid":false,"given":"Ben","family":"Sessa","sequence":"additional","affiliation":[{"name":"Division of Brain Sciences, Faculty of Medicine, Imperial College London, Center for Neuropsychopharmacology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Das","sequence":"additional","affiliation":[{"name":"Clinical Psychopharmacology Unit, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-3635","authenticated-orcid":false,"given":"Benjamin","family":"Rolland","sequence":"additional","affiliation":[{"name":"University of Lyon 1, Lyon, France"},{"name":"PSY2R, INSERM U1028, CNRS UMR5292, Lyon Neuroscience Research Center, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Service Hospitalo-Universitaire d\u2019Addictologie, H\u00f4pital Edouard Herriot, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2182-1644","authenticated-orcid":false,"given":"Albert","family":"Garcia-Romeu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-8683","authenticated-orcid":false,"given":"Marc","family":"Auriacombe","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Bordeaux, France"},{"name":"SANPSY, CNRS UMR 6033, Bordeaux, France"},{"name":"Addiction Clinic, Pole Inter\u00e9tablissement d\u2019Addictologie, CHU de Bordeaux et CH Charles Perrens, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596.dsm16"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12985"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.11.006"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.4324\/9781315689197-12"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2020.1808982"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102857"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pbr.2018.08.002"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1607956"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565144"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2015.03.002"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00100"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1376"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2096"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1320802"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pbr.2018.08.005"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2018.1447174"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.39"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.08.009"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19070684"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.005"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18101123"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06063-2"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13162-w"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30337-7"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-06009-x"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/01947648.2011.550832"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316638008"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.017"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00943"},{"key":"e_1_3_3_31_1","first-page":"1541","article-title":"The CARE guidelines: Consensus-based clinical case reporting guideline development","volume":"53","author":"Gagnier JJ","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, et al. (2013) The CARE guidelines: Consensus-based clinical case reporting guideline development. Headache 2013; 53: 1541\u20131547.","journal-title":"Headache 2013"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00955"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119845793"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000084"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473708666150107121331"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109828"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.21030277"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0457-5"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12060782"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2017.1290855"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-154"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114548296"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116684335"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.11.010"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08085-4"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00277"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaa087"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112439253"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00275-1"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1997.10400185"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2007.10399860"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.4.354"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1112-2"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2012.704590"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2013.873157"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.022"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04054.x"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114568040"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2018.1447175"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00529"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb08242.x"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0099-9598(01)56012-5"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05213.x"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.695335"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118780612"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00192"},{"key":"e_1_3_3_68_1","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372: n71.","journal-title":"BMJ"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1970.03170240060010"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30819-X"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13587"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2009.06.002"},{"key":"e_1_3_3_73_1","first-page":"273","article-title":"Prelminary report on the experience with psychosomimetic drugs in the treatment of alcobolism","volume":"10","author":"Rydzy\u0144ski Z","year":"1968","unstructured":"Rydzy\u0144ski Z, Cwynar S, Grzelak L, et al. (1968) Prelminary report on the experience with psychosomimetic drugs in the treatment of alcobolism. Act Nerv Super (Praha) 10: 273.","journal-title":"Act Nerv Super (Praha)"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-021815-093351"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00733"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.12.024"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.11.004"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881121991792"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2008.00134.x"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2009.11.024"},{"key":"e_1_3_3_81_1","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. (2016) ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355: i4919.","journal-title":"BMJ"},{"key":"e_1_3_3_82_1","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al. (2019) RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 366: l4898.","journal-title":"BMJ"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.02.017"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.2174\/15733998113099990003"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06298.x"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473711205010003"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0661-4"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2884"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.11.001"},{"key":"e_1_3_3_91_1","unstructured":"Wells GA Shea B O\u2019Connell D et al. (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473708666150107120011"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.05.006"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811241308613","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811241308613","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811241308613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:02:10Z","timestamp":1782205330000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811241308613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/02698811241308613"],"URL":"https:\/\/doi.org\/10.1177\/02698811241308613","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]}}}